Dr. Peter Ball held a series of senior global technical and commercial roles at Pall Corporation (now part of the Danaher group) spanning Research and Development, Strategic Marketing, and Business Development within the Life Sciences market space.
Peter's experience spans intellectual property landscape review (as part of technology licensing and acquisition) small company acquisition and post-acquisition integration, new product portfolio planning, and product development from ideation to launch. He has worked with a number of early-stage start-ups, both whilst at Pall since leaving them to work as a mentor within Panacea Innovation’s accelerator program.
Peter's technical and market experience covers many aspects of pharmaceutical product manufacturing, particularly bioprocessing, together with Clinical Diagnostics, Drug Discovery Rapid Microbiology, and medical devices. He is an enthusiastic, open-minded, technically knowledgeable, and entrepreneurial individual passionate about helping those starting their own company to manage successfully the challenges they face.
Current role